Servier India, part of the global Servier Group headquartered in France, is dedicated to therapeutic progress and excellence in healthcare. We focus on research, development, manufacturing, and promotion of original pharmaceutical products across cardiology, metabolic disorders, venous diseases, neuropsychiatry, and oncology, including hard-to-treat cancers. Our patient-centric approach integrates patient insights throughout the product lifecycle. We serve healthcare professionals, hospitals, clinics, and patients, ensuring access to innovative treatments. With a commitment to scientific excellence and ethical promotion, Servier India advances medical science, improves healthcare outcomes, and positively impacts the health of the Indian population.